Blocking Notch activation to prevent M1 activation at the early stage, or applying lnc-ip65 to restrain hyperactivation of M1 at the late stage, might be effective for the control of inflammation and NF-κB-associated autoimmune diseases. The gene discussed is NFKB1; the disease is autoimmune disease.